Product Information
NEOMYCIN-POLY-HC EYE DROPS is a generic product labeled by Sandoz Inc., priced at $17.6387 per ML under NDC 61314064175. Its NADAC has been published 631 times since Nov 28, 2013.
FDA first approved this application on May 11, 1988.
Strength
10; 3.5; 10000 mg/mL; mg/mL; [USP'U]/mL
Manufacturer
Sandoz Inc.NDC
61314064175
Classification
Generic
Dosage Form
SUSPENSION
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA062874FDA Approved
5/11/1988
On Market Since
5/9/2003
Pharmacological Classes
Price Statistics
The NADAC for NEOMYCIN-POLY-HC EYE DROPS has been published 631 times since Nov 28, 2013, and over the history we have for it it has risen 27.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $17.6387 per ML |
|---|---|
| All-time high | $19.1688 (May 13, 2026) |
| All-time low | $13.4327 (Dec 18, 2013) |
| 52-week high | $19.1688 |
| 52-week low | $17.6387 |
| Median price | $16.5043 |
| Average price | $16.2642 |
| Largest weekly change | +15.0% (Jun 19, 2019) |
| Weeks tracked | 631 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 78% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
neomycin sulfate, polymyxin b sulfate and hydrocortisone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminoglycoside Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NEOMYCIN-POLY-HC EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for NEOMYCIN-POLY-HC EYE DROPS, manufactured by Sandoz Inc., is $17.6387 per ML (NDC 61314064175), effective Sep 30, 2026.
How has the price of NEOMYCIN-POLY-HC EYE DROPS changed over time?
Over the history we have for it, the NADAC for NEOMYCIN-POLY-HC EYE DROPS has risen 27.2%. It has been tracked across 631 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NEOMYCIN-POLY-HC EYE DROPS?
Since Nov 28, 2013, the NADAC for NEOMYCIN-POLY-HC EYE DROPS has ranged from a low of $13.4327 (Dec 18, 2013) to a high of $19.1688 (May 13, 2026), with a median of $16.5043 per ML.
Are there cheaper alternatives to NEOMYCIN-POLY-HC EYE DROPS?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NEOMYCIN-POLYMYXIN-HC EAR SUSP, is $3.8331 per ML — about 78% below NEOMYCIN-POLY-HC EYE DROPS.
Who manufactures NEOMYCIN-POLY-HC EYE DROPS?
NEOMYCIN-POLY-HC EYE DROPS (NDC 61314064175) is labeled by Sandoz Inc., and CMS classifies it as a generic product.